Opiate receptor blockade on human granulosa cells inhibits VEGF release

Fabian Lunger1, Anni P Vehmas2, Barbara G Fürnrohr3

  • 1Department of Gynecologic Endocrinology and Reproductive Medicine, Medical University of Innsbruck, Innsbruck, Austria.

Insights

Human granulosa cells express the main opioid receptor (OPRM1). Blocking OPRM1 signaling with naloxone significantly reduced vascular endothelial growth factor (VEGF) production, suggesting a therapeutic target for ovarian hyperstimulation syndrome.

Area of Science:

  • Reproductive Biology
  • Endocrinology
  • Cell Biology

Background:

  • Granulosa cells play a crucial role in ovarian function and follicle development.
  • Vascular Endothelial Growth Factor (VEGF) is vital for angiogenesis and is implicated in ovarian physiology.
  • The role of opioid signaling in human granulosa cells is not well understood.

Purpose of the Study:

  • To determine the presence of the main opioid receptor (OPRM1) on human granulosa cells.
  • To investigate the influence of exogenous opiates and antagonists on granulosa cell VEGF production via OPRM1.

Main Methods:

  • Human granulosa cells were isolated from women undergoing oocyte retrieval for IVF.
  • Experiments utilized the human granulosa cell line COV434.
  • OPRM1 presence was confirmed using Western blot and flow cytometry.
  • VEGF secretion was measured by ELISA after opiate antagonist treatment.

Main Results:

  • The study confirmed the presence of OPRM1 on human granulosa cells for the first time.
  • Naloxone, a specific OPRM1 antagonist, significantly reduced VEGF levels in both COV434 and granulosa-luteal cells (P < 0.01).

Conclusions:

  • Human granulosa cells express OPRM1, indicating a functional opioid signaling pathway.
  • Opioid signaling significantly influences granulosa cell VEGF production.
  • Targeting the OPRM1 pathway may offer novel therapeutic strategies for ovarian hyperstimulation syndrome.

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.7K
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
4.9K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.9K
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
8.3K